Short description
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.
Description
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock.
Total funding
$$3123123
Sign in for full access
Location
Geleen, Limburg, The Netherlands, Europe
Founded on
January 1, 2014
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noway Youcantaccess, Noaccess, Nopepepe
Sign in for full access